Biotheus, a biotech company focused on curing malignant tumors and autoimmune diseases, has secured an undisclosed amount of funding. General Atlantic and IDG Capital led the round.
Source: Press Release
General Atlantic and IDG Capital back Biotheus
Biotheus, a biotech company focused on curing malignant tumors and autoimmune diseases, has secured an undisclosed amount of funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: